4.8 Article

Prioritizing Parkinson's disease genes using population-scale transcriptomic data

期刊

NATURE COMMUNICATIONS
卷 10, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41467-019-08912-9

关键词

-

资金

  1. US National Institutes of Health (NIH) [R01AG054005]
  2. Michael J. Fox Foundation
  3. Takeda Pharmaceuticals Company Limited
  4. F. Hoffman-La Roche Ltd
  5. NIH [R01MH085542, R01MH093725, P50MH066392, P50MH080405, R01MH097276, RO1-MH-075916, P50M096891, P50MH084053S1, R37MH057881, R37MH057881S1, HHSN271201300031C]
  6. [AG02219]
  7. [AG05138]
  8. [MH06692]
  9. [P30AG10161]
  10. [U01AG046152]
  11. [R01AG16042]
  12. [R01AG036836]
  13. [R01AG015819]
  14. [R01AG017917]
  15. [R01AG036547]

向作者/读者索取更多资源

Genome-wide association studies (GWAS) have identified over 41 susceptibility loci associated with Parkinson's Disease (PD) but identifying putative causal genes and the underlying mechanisms remains challenging. Here, we leverage large-scale transcriptomic datasets to prioritize genes that are likely to affect PD by using a transcriptome-wide association study (TWAS) approach. Using this approach, we identify 66 gene associations whose predicted expression or splicing levels in dorsolateral prefrontal cortex (DLFPC) and peripheral monocytes are significantly associated with PD risk. We uncover many novel genes associated with PD but also novel mechanisms for known associations such as MAPT, for which we find that variation in exon 3 splicing explains the common genetic association. Genes identified in our analyses belong to the same or related pathways including lysosomal and innate immune function. Overall, our study provides a strong foundation for further mechanistic studies that will elucidate the molecular drivers of PD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据